Strict ovarian CA screening adherence called for in high-risk

December 5, 2012
Strict ovarian CA screening adherence called for in high-risk
For women at higher risk for ovarian and/or fallopian tube cancer, annual screening offers high sensitivity for detection of incident cancers, but few of these cancers are stage I or II, according to research published online Dec. 3 in the Journal of Clinical Oncology.

(HealthDay)—For women at higher risk for ovarian and/or fallopian tube cancer (OC/FTC), annual screening offers high sensitivity for detection of incident cancers, but few of these cancers are stage I or II, according to research published online Dec. 3 in the Journal of Clinical Oncology.

Between 2002 and 2008, Adam N. Rosenthal, M.D., Ph.D., of Barts and the London School of Medicine and Dentistry, and colleagues screened 3,563 women who were estimated to be at a 10 percent or higher of OC/FTC. Women were evaluated using transvaginal ultrasound and serum CA125 screening and followed prospectively.

The researchers found that, at one year after the last annual screening, the sensitivity for detection of incident OC/FTC was 81.3 or 87.5 percent if occult cancers were classified as false negatives or true positives, respectively. For incident screening, the positive and negative predictive values were 25.5 and 99.9 percent, respectively. There were 13 incident screen-detected cases of OC/FTC; only four of these were stage I or II. Women who were not screened in the year before diagnosis were significantly more likely to have stage IIIc disease or higher compared with those who had been screened the year before (85.7 versus 26.1 percent). In prevalent and incident cancer, the median time between detection screen and surgical intervention was 79 days.

"These results in the high-risk population highlight the need for strict adherence to [a] screening schedule," the authors write. "Screening more frequently than annually, with prompt , seems to offer a better chance of early-stage detection."

Several authors disclosed financial ties to medical and diagnostic technology companies.

Explore further: Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

April 3, 2012
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident ...

Ovarian cancer screening does not appear to reduce risk of ovarian cancer death

June 5, 2011
In a clinical trial that included nearly 80,000 women, those who received ovarian cancer screening did not have a reduced risk of death from ovarian cancer compared to women who received usual care, but did have an increase ...

Regular smear tests boost chances of cure from 66 percent to 92 percent

March 2, 2012
Women can boost their chances of surviving cervical cancer substantially through regular cervical screening, claims a research paper published today in the British Medical Journal.

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.